Sprague-Dawley and Fischer Female Rats Differ in Acute Effects of Fluoxetine on Sexual Behavior
Open Access
- 1 February 2013
- journal article
- research article
- Published by Oxford University Press (OUP) in The Journal of Sexual Medicine
- Vol. 10 (2) , 350-361
Abstract
The selective serotonin reuptake inhibitor (SSRI), fluoxetine, leads to sexual dysfunction in a substantial proportion of women. In studies with the Fischer inbred rat, the 5‐HT1A receptor has been implicated in this sexual dysfunction. Whether this association with 5‐HT1A receptors holds for other rat strains is not known. The effects of acute fluoxetine on sexual behavior in two strains of rats that differ in their response to a 5‐HT1A receptor agonist were examined. Whether the strain difference is comparable in naturally cycling and hormonally primed, ovariectomized rats was determined. Proestrous rats and ovariectomized rats, hormonally primed with estradiol benzoate and progesterone, were treated with varying doses of fluoxetine. Sexual behavior was examined before and after treatment with the SSRI. Lordosis to mount ratios, lordosis quality, and proceptive behaviors were quantified. Sprague‐Dawley and Fischer females were compared on each of these measures. The IC50 for inhibition of lordosis behavior was determined. In both the intact and the hormonally primed, ovariectomized model, Sprague‐Dawley females were less sensitive to the effects of fluoxetine on sexual behavior. In both groups, fluoxetine showed dose dependency in behavioral inhibition, but a higher dose was required for Sprague‐Dawley than for Fischer females. Naturally cycling, proestrous rats required a higher dose of fluoxetine than hormonally primed ovariectomized rats to produce significant inhibition of sexual behavior. Thus, the strain difference in the response to fluoxetine does not parallel strain differences in the response to a 5‐HT1A receptor agonist. Acute treatment with fluoxetine inhibits lordosis behavior in both Fischer and Sprague‐Dawley females and the strain difference cannot be explained by reported strain differences in the response to a 5‐HT1A receptor agonist. Fluoxetine's inhibition of female rat sexual behavior may involve effects of the SSRI in addition to activation of the 5‐HT1A receptor. Miryala CSJ, Hiegel C, and Uphouse L. Sprague‐Dawley and Fischer female rats differ in acute effects of fluoxetine on sexual behavior. J Sex Med **;**:**–**.Keywords
This publication has 65 references indexed in Scilit:
- Female Sexual Dysfunction in Patients Treated with Antidepressant—Comparison Between Escitalopram and FluoxetineThe Journal of Sexual Medicine, 2012
- Barriers to achieving treatment goals: A focus on sleep disturbance and sexual dysfunctionJournal of Affective Disorders, 2011
- Sexual dysfunction during treatment with serotonergic and noradrenergic antidepressants: Clinical description and the role of the5-HTTLPRThe World Journal of Biological Psychiatry, 2011
- A New Female Rat Animal Model for Hypoactive Sexual Desire Disorder; Behavioral and Pharmacological EvidenceThe Journal of Sexual Medicine, 2011
- Fluoxetine-Induced Decrements in Sexual Responses of Female Rats and Hamsters Are Reversed by 3α,5α-THPThe Journal of Sexual Medicine, 2010
- Role of 5-HT1A receptors in fluoxetine-induced lordosis inhibitionHormones and Behavior, 2010
- Strain differences in proliferation of progenitor cells in the dentate gyrus of the adult rat and the response to fluoxetine are dependent on corticosteroneNeuroscience, 2008
- Modest effects of repeated fluoxetine on estrous cyclicity and sexual behavior in Sprague Dawley female ratsBrain Research, 2008
- FluoxetineCNS Drugs, 2000
- Chronic effects of atrazine on estrus and mammary tumor formation in female Sprague‐Dawley and Fischer 344 ratsJournal of Toxicology and Environmental Health, 1994